Bibliografía

  1. Altman A, Deckert M. The function of small GTPases in signaling by immune recognition and other leukocyte receptors. Adv Immunol 72: 1-101, 1999
  2. Izquierdo M, Downward J, Graves JD, Cantrell DA. Role of protein kinase C in T cell antigen receptor regulation of p21ras: Evidence that two p21ras regulatory pathways coexist in T cells. Mol Cell Biol 12: 3305-3312, 1993
  3. Ohtsuka T, Kaziro Y, Satoh T. Analysis of the T cell activation signaling pathway mediated by tyrosine kinases, protein kinase C, and Ras protein, which is modulated by intracellular cyclic AMP. Biochem Biophys Acta 1310: 223-232, 1996
  4. Lin K, Abraham KM. Targets of p56Lck activity in inmature thymoblasts: Stimulation of the Ras/Raf/MAPK pathway. Intl Immunol 9: 291-306, 1997
  5. Downward J, Graves JD, Warne PH, Rayter S, Cantrell DA. Stimulation of p21ras upon T-cell activation. Nature 346: 719-723, 1990
  6. Williams DH, Woodrow M, Cantrell DA. Protein kinase C is not a downstream effector of p21ras in activated T cells. Eur J Immunol 25: 42-47, 1995
  7. Boriack-Sjodin PA, Margarit SM, Bar-Sagi D, Kuriyan J. The structural basis of the activation of Ras by Sos. Nature 394: 337-343, 1998
  8. Pratt JC, van den Brink MRM, Igras VE, Walk SF, Ravichandram KS, Burakoff SJ. Requirement for Shc in TCR-mediated activation of a T cell hybridoma. J Immunol 163: 2586-2591, 1999
  9. Lowestein EJ, Daly RJ, Baltzer AG, Li W, Margolis B, Lammers R, Ulrich A, Skolnik EY, Bar Sagi D, Schlesinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to Ras signaling. Cell 70: 431-442, 1992
  10. Koretzky GA. The role of Grb2-associated proteins in T-cell activation. Immunol Today 18: 401-406, 1997
  11. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. LAT: the ZAP-70 tyrosine kinase substrate that links the T cell receptor to cellular activation. Cell 92: 83-92, 1998
  12. Lupher ML, Rao N, Eck MJ, Band H. The Cbl protooncoprotein: a negative regulator of immune receptor signal transduction. Immunol Today 20: 375-382, 1999
  13. Schraven B, Cardine AM, Hubener C, Bruyns E, Ding I. Integration of receptor-mediated signals in T cells by transmembrane adaptor proteins. Immunol Today 20: 431-434, 1999
  14. Jackmant JK, Motto DG, Koretzky GA. Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J Biol Chem 270: 7029-7032, 1995
  15. Clements JL, Yang B, Ross-Barta SE, Eliason SL, Hrstka RF, Williamson RA, Koretzky GA. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science 282: 416-420, 1998
  16. Yablonski D, Kuhne MR, Kadlecek T, Weiss A. Uncoupling of nonreceptor tyrosine kinases from PLC-g 1 in a SLP-76-deficient T cell. Science 281: 413-416, 1998
  17. Fang N, Motto DG, Ross SE, Koretzky GA. Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J Immunol 157: 3769-3773, 1996
  18. Musci MA, Motto DG, Ross SE, Fang N, Koretzky GA. Three domains of SLP-76 are required for its optimal function in a T cell line. J Immunol 159: 1639-1647, 1997
  19. Clements JL, Koretzky GA. Recent developments in lymphocyte activation: linking kinases to downstream signaling events. J Clin Invest 103: 925-929, 1999
  20. Lupher ML, Songyang Z, Shoelson SE, Cantley LC, Band H. The Cbl phosphotyrosine-binding domain selects a D9N/DxpY motif and binds to the Tyr 292 negative regulatory phosphorylation site. J Biol Chem 272: 33140-33144, 1997
  21. Thien CBF, Bowtell DDL, Lagndon WY. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in Cbl-deficient thymocytes. J Immunol 162: 7133-7139, 1999
  22. Moran M, Miceli MC. Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: A role for lipid rafts in T cell activation. Immunity 9: 787-796, 1998
  23. Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA, Chauvin JP, Pierres M, He HT. Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J 17: 5334-5348, 1998
  24. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 9: 726-735, 1995
  25. Fabian JR, Daar IO, Morrison DK. Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. Mol Cell Biol 13: 7170-7179, 1993
  26. Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U, Asworth A, Marshall CJ, Cowley S. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74Raf-1. EMBO J 13: 1610-1619, 1994
  27. Haystead TA, Dent P, Sturgill TW, Marshak DR. Ordered phosphorylation of p42 mapk by MAP kinase kinase. FEBS lett 13: 17-22, 1992
  28. Alberola-Ila J, Forbusch KA, Seger R, Krebs EG, Perlmutter RM. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373: 620-632, 1996
  29. D’Ambrossio D, Cantrell DA, Frati L, Santoni A, Testi R. Involvement of p21 ras activation in T cell CD69 expression. Eur J Immunol 24: 616-620, 1994
  30. Sirinian MI, Marchetti A, Di Rocco G, Starace G, Jucker R, Nasi S. Ras oncogen transformation of human B lymphoblasts is associated with lymphocyte activation and with a block of differentiation. Oncogene 8: 157-163, 1993
  31. Wotton D, Ways DK, Parker PJ, Owen MJ. Activity of both Raf and Ras is necessary for activation of transcription of the human T cell receptor b gene by protein kinase C, Ras plays multiple roles. J Biol Chem 268: 17975-17982, 1993
  32. Synkowsky DR, Provost TT. Characterization of the inflammatory infiltrate in lupus erythematosus lesions using monoclonal antibodies. J Rheumatol 10: 920-924, 1983
  33. Caligaris-Cappio F, Bergui L, Tesio L, Ziano R, Camussi G. HLA-DR+ T cells of the Leu3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus. Clin Exp Immunol 59: 185-189, 1985
  34. Shlomchick M, Mascelli M, Shan H, Radic MZ, Pisetsky D, Marshak-Rothstein A, Weigert M. Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 171: 265-297, 1990
  35. Stekman IL, Blasini AM, Leon-Ponte M, Baroja ML, Abadi I, Rodriguez MA: Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus. Arthritis Rheum 34:459-467, 1991
  36. Blasini AM, Stekman IL, Gonzalez F, Tositti ML, Rodriguez MA: T lymphocytes from patients with systemic lupus erythematosus show increased response to interleukin-2 after costimulation with OKT3 monoclonal antibody and phorbol esters. Clin Immunol Immunopathol 70: 66-72, 1994
  37. Vassilopoulos D, Kovacs B, Tsokos GC. TCR/CD3 complex-mediated signal transduction in T cells and T cell lines from patients with systemic lupus erythematosus. J Immunol 155: 2269-2281, 1995
  38. Koshy M, Berger D, Crow MK. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98: 826, 837, 1996
  39. Tsokos GC, Liossis SNC. Immune cell signaling defects in lupus: activation, anergy and death. Immunol Today 20: 119-124, 1999
  40. Zouali M. Signaling in human lupus T lymphocytes. Lupus 7: 499-502, 1998
  41. Kammer GM, Khan IU, Malemud CJ. Deficient type I protein kinase A isoenzyme activity in systemic lupus erythematosus. J Clin Invest 94: 422-430, 1994
  42. Blasini AM, Alonzo E, Chacon R, Riera R, Stekman IL, Rodriguez MA. Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Lupus 7:515-523, 1998
  43. Liossis SN, Ding XZ, Dennis GJ, Tsokos GC. Altered pattern of TCR/CD3-mediated protein-tyrosine phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the TCR z chain. J Clin Invest 101: 1448-1457, 1998
  44. Chan AC, Desai DM, Weiss A. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Ann Rev Immunol 12:555-592, 1994
  45. Blasini AM, Brundula V, Paris M, Rivas L, Salazar S, Stekman IL, Rodriguez MA. Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus. J Autoimm 11: 387-394, 1998
  46. Brundula V, Rivas L, Blasini AM, Paris M, Salazar S, Stekman IL, Rodríguez MA. Diminished levels of TCR z chain in peripheral blood (PB) T lymphocytes from patients with systemic lupus erithematosus (SLE). Arthritis Rheum, 42: 1908-1916, 1999
  47. Tsuzaka K, Takeuchi T, Onoda N, Pang M, Abe T. Mutations in T cell receptor z chain mRNA of peripheral T cells from systemic lupus erythematosus patients. J Autoimmun 11: 381-386, 1998
  48. Fields PE, Gajewski TF, Fitch FW. Blocked Ras activation in anergic CD4+ T cells . Science 271: 1276-1278, 1996
  49. Li W, Whaley C, Mondino A, Mueller DL. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science 271: 1272-1275, 1996
  50. Salojin K, Zhang J, Cameron M, Gill B, Arreaza G, Ochi A, Delovitch TL. Impaired plasma membrane targeting of Grb2-murine son of sevenless (mSos) complex and differential activation of the Fyn-T cell receptor (TCR)-z -Cbl pathway mediate T cell hyporesponsiveness in autoimmune nonobese diabetic mice. J Clin Invest 186: 887-897, 1997
  51. Salojin KV, Zhang J, Madrenas J, Delovitch TL. T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease. Immunol Today 19: 468-473, 1998
  52. Liang K|HE, Hsueh YP, Wu CC, Han SH, Lai MZ. Atypical signaling defects prevent Il-2 gene expression in lpr/lpr CD4-CD8- cells. J Biomed Sci 5: 297-304, 1998
  53. Rapoport MJ, Amit M, Rosenberg R, Ramot Y, Mizrachi A, Wysenbeek AJ. Decreased expression of the p21ras stimulatory factor hSos in PBMC from inactive SLE patients. Lupus 8: 24-28, 1999
  54. Cifarelli F. Papel de la proteína adaptadora Grb2 en la señalización intracelular vía TCR/CD3 en linfocitos T de pacientes con lupus eritematoso sistémico. Trabajo Especial de Grado para optar al título de Licenciado en Biología. Escuela de Biología, Facultad de Ciencias, Universidad Central de Venezuela 1999.